228 related articles for article (PubMed ID: 8601418)
1. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
Burgaud JL; Baserga R
Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism.
Eisinger DA; Ammer H
Mol Pharmacol; 2011 Feb; 79(2):326-35. PubMed ID: 21078885
[TBL] [Abstract][Full Text] [Related]
4. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes.
Hallak H; Moehren G; Tang J; Kaou M; Addas M; Hoek JB; Rubin R
Hepatology; 2002 Dec; 36(6):1509-18. PubMed ID: 12447877
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
10. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.
Rubini M; Hongo A; D'Ambrosio C; Baserga R
Exp Cell Res; 1997 Feb; 230(2):284-92. PubMed ID: 9024787
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide.
Zhou Q; Meng D; Yan B; Jiang BH; Fang J
FEBS Lett; 2006 Oct; 580(22):5161-6. PubMed ID: 16970944
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor.
DeAngelis T; Ferber A; Baserga R
J Cell Physiol; 1995 Jul; 164(1):214-21. PubMed ID: 7790393
[TBL] [Abstract][Full Text] [Related]
13. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
14. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.
Helin K; Velu T; Martin P; Vass WC; Allevato G; Lowy DR; Beguinot L
Oncogene; 1991 May; 6(5):825-32. PubMed ID: 1646987
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
16. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
[TBL] [Abstract][Full Text] [Related]
17. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
18. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
[TBL] [Abstract][Full Text] [Related]
19. Gene regulation by IGF-I.
Baserga R
Mol Reprod Dev; 1993 Aug; 35(4):353-6; discussion 356-7. PubMed ID: 8398113
[TBL] [Abstract][Full Text] [Related]
20. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
Miura M; Li S; Baserga R
Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
